UiPath Inc. (NYSE:PATH) Receives $17.47 Average Target Price from Brokerages

Shares of UiPath Inc. (NYSE:PATH) have earned a consensus recommendation of “Hold” from the eighteen ratings firms that are covering the company, Marketbeat Ratings reports. Sixteen research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $17.47.

Several equities analysts have issued reports on PATH shares. JPMorgan Chase & Co. dropped their price objective on UiPath from $19.00 to $17.00 and set an “overweight” rating on the stock in a report on Wednesday, October 23rd. DA Davidson lifted their price target on UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Morgan Stanley reissued an “equal weight” rating and issued a $15.00 price objective on shares of UiPath in a report on Friday, September 6th. Bank of America lifted their target price on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Finally, Wells Fargo & Company decreased their price target on shares of UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd.

UiPath Stock Performance

Shares of NYSE PATH opened at $12.48 on Friday. The stock’s 50-day simple moving average is $12.51 and its 200-day simple moving average is $13.98. The firm has a market capitalization of $6.86 billion, a PE ratio of -62.37 and a beta of 0.88. UiPath has a fifty-two week low of $10.37 and a fifty-two week high of $27.87.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. The company’s revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.09) EPS. On average, sell-side analysts forecast that UiPath will post -0.23 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at $10,258,498.19. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 22.37% of the company’s stock.

Institutional Trading of UiPath

Institutional investors have recently added to or reduced their stakes in the stock. Future Financial Wealth Managment LLC acquired a new stake in UiPath in the 3rd quarter valued at about $26,000. JTC Employer Solutions Trustee Ltd purchased a new position in shares of UiPath during the 3rd quarter worth approximately $26,000. ORG Partners LLC increased its stake in shares of UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after purchasing an additional 1,112 shares in the last quarter. Hantz Financial Services Inc. acquired a new position in shares of UiPath during the 2nd quarter worth approximately $28,000. Finally, Redwood Wealth Management Group LLC purchased a new stake in UiPath in the 2nd quarter valued at approximately $43,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.